Drug-drug interactions involving membrane transporters in the human kidney (Q36543091)

14 August 2017

1 reference

title

Drug-drug interactions involving membrane transporters in the human kidney (English)

1 reference

14 August 2017

0 references

Meng Li

1

1 reference

14 August 2017

Gail D Anderson

series ordinal

2

1 reference

14 August 2017

Joanne Wang

series ordinal

3

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

Expert Opinion on Drug Metabolism & Toxicology

14 August 2017

1 reference

14 August 2017

2

1 reference

14 August 2017

4

1 reference

14 August 2017

505-532

1 reference

Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs

14 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Transporter-mediated Drug Interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

The role of transporters in drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Drug interactions at the renal level. Implications for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Molecular and cellular physiology of renal organic cation and anion transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Role of organic cation transporters in drug absorption and elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Peptide transporters in the intestine and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Mammalian nucleoside transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Cellular and molecular aspects of drug transport in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Transporters and renal drug elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Mechanisms and clinical implications of renal drug excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

A human transporter protein that mediates the final excretion step for toxic organic cations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Molecular physiology of renal organic anion transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Structure, function, and regulation of renal organic anion transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Molecular aspects of renal anionic drug transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Isolation of a family of organic anion transporters from human liver and kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Human Organic Anion Transporter 3 (hOAT3) can Operate as an Exchanger and Mediate Secretory Urate Flux

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Role of human organic anion transporter 4 in the transport of ochratoxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

The superfamily of organic anion transporting polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Function and regulation of multidrug resistance proteins (MRPs) in the renal elimination of organic anions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

The SLC22 drug transporter family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Na(+)-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Involvement of OCTN1 (SLC22A4) in pH-dependent transport of organic cations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Discovery of the ergothioneine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Biochemical, cellular, and pharmacological aspects of the multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Role of P-glycoprotein in pharmacokinetics: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Cytosolic COOH terminus of the peptide transporter PEPT2 is involved in apical membrane localization of the protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Interactions of amoxicillin and cefaclor with human renal organic anion and peptide transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Dose-dependent absorption and elimination of cefadroxil in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Effects of renal failure on drug transport and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Pharmacokinetics of the penicillins in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Renal transport of drugs: specificity and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Clinically desirable drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Cephalosporin-probenecid drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Clinical pharmacokinetics of probenecid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Non-linear elimination and protein binding of probenecid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Pharmacodynamics of cefazolin in the presence of normal and impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Effect of Chronic Probenecid Therapy on Cefazolin Serum Concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Involvement of rat organic anion transporter 3 (rOAT3) in cephaloridine-induced nephrotoxicity: in comparison with rOAT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Effects of probenecid on the pharmacokinetics and elimination of acyclovir in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Multiple interactions of cimetidine and probenecid with valaciclovir and its metabolite acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Probenecid inhibits the metabolic and renal clearances of zidovudine (AZT) in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Human organic anion transporters and human organic cation transporters mediate renal antiviral transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Interactions of human organic anion transporters with diuretics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Characterization of methotrexate transport and its drug interactions with human organic anion transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Clinical pharmacokinetics of cimetidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Cimetidine-procainamide pharmacokinetic interaction in man: Evidence of competition for tubular secretion of basic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Pharmacokinetic interactions of cimetidine 1987.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Relative contribution of OAT and OCT transporters to organic electrolyte transport in rabbit proximal tubule

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Reduction of metformin renal tubular secretion by cimetidine in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Interactions of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Metformin transport by renal basolateral organic cation transporter hOCT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Characterization of regulatory mechanisms and states of human organic cation transporter 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Physiologically based pharmacokinetics of digoxin in mdr1a knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Digoxin-quinidine interaction Pharmacokinetic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine [seecomments]

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Characterisation of (R/S)-propafenone and its metabolites as substrates and inhibitors of P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Mechanisms of cefadroxil uptake in the choroid plexus: studies in wild-type and PEPT2 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Interaction of organic cations with a newly identified plasma membrane monoamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Identification and characterization of a novel monoamine transporter in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Interaction of human organic anion transporters with various cephalosporin antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Interactions of human- and rat-organic anion transporters with pravastatin and cimetidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Interactions of stevioside and steviol with renal organic anion transporters in S2 cells and mouse renal cortical slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Inhibition of oat3-mediated renal uptake as a mechanism for drug-drug interaction between fexofenadine and probenecid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Cloning and characterization of two human polyspecific organic cation transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Genetic variant Arg57His in human H+/peptide cotransporter 2 causes a complete loss of transport function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Differential recognition of beta -lactam antibiotics by intestinal and renal peptide transporters, PEPT 1 and PEPT 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Interaction of anionic cephalosporins with the intestinal and renal peptide transporters PEPT 1 and PEPT 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

A functional assay for quantitation of the apparent affinities of ligands of P-glycoprotein in Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Kinetics of daunorubicin transport by P-glycoprotein of intact cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Utility of 96 well Caco-2 cell system for increased throughput of P-gp screening in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

MDR1 G1199A polymorphism alters permeability of HIV protease inhibitors across P-glycoprotein-expressing epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Interaction of common azole antifungals with P glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

P-glycoprotein-dependent disposition kinetics of tacrolimus: studies in mdr1a knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

P-glycoprotein and surfactants: effect on intestinal talinolol absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Transport characteristics of fexofenadine in the Caco-2 cell model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

P-glycoprotein transports corticosterone and is photoaffinity-labeled by the steroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Direct evidence that saquinavir is transported by multidrug resistance-associated protein (MRP1) and canalicular multispecific organic anion transporter (MRP2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Potentiation by alpha-tocopheryl succinate of the etoposide response in multidrug resistance protein 1-expressing glioblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

ATP-dependent para-aminohippurate transport by apical multidrug resistance protein MRP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Comparison of furosemide and vinblastine secretion from cell lines overexpressing multidrug resistance protein (P-glycoprotein) and multidrug resistance-associated proteins (MRP1 and MRP2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Pharmacokinetics of parenteral sodium cephalexin in comparison with cephalothin and cefazolin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Effect of probenecid on the blood levels and urinary excretion of cefamandole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

The effect of probenecid on the renal elimination of cimetidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Pharmacokinetics of cephradine given intravenously with and without probenecid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

The renal clearance of cefuroxime and ceftazidime and the effect of probenecid on their tubular excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

The effect of probenecid on the pharmacokinetics of zalcitabine in HIV-positive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Pharmacokinetics of oral ganciclovir alone and in combination with zidovudine, didanosine, and probenecid in HIV-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Effect of probenecid on the distribution and elimination of ciprofloxacin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Effect of cimetidine and probenecid on pilsicainide renal clearance in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Dose and concentration dependent effect of ranitidine on procainamide disposition and renal clearance in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

Levofloxacin and ciprofloxacin decrease procainamide and N-acetylprocainamide renal clearances

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.505

21 January 2018

Identifiers

DOI

10.1517/17425255.2.4.505

1 reference

14 August 2017

1 reference